香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性或完整性亦不發表任何聲明， 並明確表示，概不對因本公佈全部或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 LIPPO CHINA RESOURCES LIMITED 力 寶 華 潤 有 限 公 司 （於香港註冊成立之有限公司） （股份代號：156） 全年業績 截至 2022年 12月 31日止年度 力寶華潤有限公司（「本公司」）之董事會公佈本公司及其附屬公司（統稱「本集團」）截至 2022 年 12月31日止年度之綜合全年業績，連同2021年同期之比較數字如下： 綜合損益表 截至2022年12月31日止年度 2022年 2021年 附註 千港元 千港元 收入 4 607,392 648,547 銷售成本 (290,930) (316,559) ───────── ───────── 溢利總額 316,462 331,988 其他收入 5 15,948 12,081 行政開支 (379,227) (392,385) 其他經營開支 7 (138,222) (149,621) 按公平值計入損益之財務工具之公平值收益 ...

Financial Performance - Revenue for the six months ended June 30, 2022, was HKD 278,995,000, a decrease of 13.1% from HKD 320,863,000 in 2021[3] - Total profit for the period was HKD 141,252,000, down 14.2% from HKD 164,709,000 in the previous year[3] - The company reported a loss attributable to equity holders of HKD 132,946,000, compared to a profit of HKD 167,779,000 in 2021, representing a significant decline[3] - The basic and diluted loss per share for the period was HKD (1.45), compared to earnings of HKD 1.83 per share in 2021[3] - The company reported a net loss before tax of HKD (128,090,000), compared to a profit before tax of HKD 156,111,000 in the previous year[3] - Total comprehensive income for the period amounted to a loss of HKD 170,240 thousand, significantly down from a profit of HKD 97,669 thousand in the same period last year[17] - The group reported a pre-tax loss of HKD 128,090,000 for the period[31] - The food business segment generated revenue of HKD 254 million, down from HKD 294 million in 2021, with increased losses of HKD 67 million compared to HKD 37 million in the previous year[114] Assets and Liabilities - The company's total assets decreased to HKD 3,720,972,000 from HKD 4,261,941,000, reflecting a decline of 12.7%[12] - Total assets as of June 30, 2022, amounted to HKD 4,685,439, a decrease from HKD 5,004,747 as of December 31, 2021[38] - The company reported a total liability of HKD 1,442,614 as of June 30, 2022[38] - The company’s non-current liabilities decreased to HKD 478,147,000 from HKD 799,976,000, indicating a reduction of 40.2%[12] - Total liabilities decreased to HKD 1.4 billion as of June 30, 2022, from HKD 1.5 billion on December 31, 2021[140] Cash Flow and Investments - Cash and cash equivalents as of June 30, 2022, were HKD 596,193,000, down from HKD 783,321,000 at the end of 2021, a decrease of 23.9%[11] - Cash flow from operating activities showed a net outflow of HKD 101,855 thousand, a decline from a net inflow of HKD 33,336 thousand in the previous year[19] - The company incurred a net cash outflow from investing activities of HKD 15,891 thousand, slightly improved from HKD 16,040 thousand in the prior year[19] - Financing activities resulted in a net cash outflow of HKD 63,218 thousand, a significant decrease from HKD 320,364 thousand in the previous year[19] Segment Performance - The property investment segment reported a loss of HKD 6,439,000, while the food business segment incurred a loss of HKD 66,862,000[31] - The healthcare services segment recorded a loss of HKD 920,000, and the securities investment segment had a significant loss of HKD 19,922,000[31] - The food business generated revenue of HKD 125,123, down from HKD 152,841, reflecting a decline of 18.2%[38] - The healthcare services reported a loss of HKD 37,273, compared to a profit of HKD 210,499 in the previous period[38] Dividends and Shareholder Information - The company declared a dividend of HKD 41,341 thousand for the year-end 2021, compared to HKD 50,528 thousand in the previous year[19] - The interim dividend declared is HKD 0.35 per share, totaling HKD 32,154,000 for the six months ended June 30, 2022, compared to no dividend in 2021[66] - The company reported a total of 9,186,912,716 issued and fully paid ordinary shares as of June 30, 2022, unchanged from December 31, 2021[79] Economic and Market Conditions - The company faced significant operational challenges due to the ongoing pandemic and inflationary pressures affecting input costs[114] - The overall economic environment remains challenging, influenced by the ongoing Russia-Ukraine conflict and inflationary pressures[110] - The company anticipates a challenging operating environment in the second half of 2022 due to rising inflation and tightening monetary policies by major central banks[149] Corporate Governance - The company has established an audit committee consisting of three independent non-executive directors and one non-executive director[184] - The board believes that good corporate governance practices are increasingly important for maintaining and enhancing investor confidence[187] - The company has complied with the corporate governance code as set out in the Listing Rules during the six months ended June 30, 2022[187]

Financial Performance - The company recorded a consolidated profit attributable to shareholders of HKD 49 million for the year ended December 31, 2021, compared to a consolidated loss of HKD 12 million for the previous nine-month period [5]. - Total revenue for the year was HKD 649 million, an increase from HKD 492 million in 2020, with the food business accounting for 92% of total revenue [13]. - Other operating expenses for the year amounted to HKD 150 million, up from HKD 140 million in 2020 [13]. - The food business segment recorded revenue of HKD 596 million for the year, up from HKD 446 million in 2020, primarily driven by retail operations in coffee shops and restaurants [15]. - The food manufacturing business faced challenges due to COVID-19 restrictions, leading to an increase in segment losses to HKD 67 million, compared to HKD 23 million in 2020 [15]. - Property investment segment revenue totaled HKD 22 million, an increase from HKD 17 million in 2020, with a reduction in fair value losses to HKD 7 million from HKD 61 million in the previous year [17]. - Financial and securities investment segment recorded total income of HKD 19 million, consistent with 2020, while net fair value gains from securities investments increased to HKD 218 million from HKD 128 million [19]. - The financial and securities investment segment achieved a net profit of HKD 215 million, up from HKD 138 million in 2020 [19]. - The group recorded a fair value gain of HKD 43,000,000 from its investment in Ascapia, primarily driven by strong performance in the non-essential consumer goods sector [26]. - The fair value of long-term strategic stock investments as of December 31, 2021, was HKD 79,000,000, down from HKD 103,000,000 in 2020, with a net fair value loss of HKD 52,000,000 for the year [28]. Investments and Acquisitions - Healthway Medical Corporation Limited, a joint venture, acquired a chain of nine clinics, becoming the largest chain of outpatient clinics in Singapore [6]. - The company achieved significant fair value gains from its investments in listed securities and non-listed investment funds, benefiting from the growth in technology-related consumption and healthcare sectors [6]. - The investment in Quantedge had a fair value of HKD 85 million, representing 7.5% of the financial assets at fair value, with a net fair value gain of HKD 14 million for the year [24]. - The investment in GSH had a fair value of HKD 79 million, with an unrealized fair value loss of HKD 7 million for the year [25]. - Healthway Medical Corporation's revenue significantly increased, leading to a higher attributable profit of HKD 25,000,000 for the group in 2021, compared to HKD 7,000,000 in 2020 [31]. - The group's equity in Healthway was valued at HKD 443,000,000 as of December 31, 2021, an increase from HKD 431,000,000 in 2020 [31]. - HMC Group expanded its operations by acquiring a chain of 9 clinics to meet the growing demand for primary healthcare services in Singapore [33]. Dividends and Shareholder Returns - The board proposed a final cash dividend of HKD 0.45 per share for the year [9]. - The proposed final dividend for the year is HKD 0.45 per share, totaling approximately HKD 41,300,000, compared to HKD 0.35 per share and approximately HKD 32,200,000 in the previous year [47]. - As of December 31, 2021, the distributable reserves of the company amounted to HKD 206,868,000 [59]. Operational Challenges and Outlook - The company is prepared to seize opportunities as global economic activities and international tourism improve, while remaining vigilant to operational risks such as geopolitical conflicts and supply chain disruptions [8]. - The group expects economic growth in 2022 to be lower than previously anticipated due to rising energy prices and supply chain disruptions [41]. - The company plans to continue focusing on its food retail and manufacturing businesses despite ongoing challenges from the pandemic [16]. Employee and Management Information - Employee costs for the year, including director remuneration, were HKD 315,000,000, an increase from HKD 218,000,000 in the previous year [40]. - The group had 787 full-time employees as of December 31, 2021, down from 945 full-time employees a year earlier [40]. - The company has a strong management team with extensive experience in finance and corporate governance [70][72][74][75]. - The company emphasizes the importance of market-level compensation for its directors and executives [78]. - The company has a structured approach to determining director compensation based on market standards and responsibilities [78]. Corporate Governance and Compliance - The company has received annual confirmation letters regarding the independence of its independent non-executive directors, affirming their status as independent individuals [67]. - The company’s board members and CEO have disclosed their interests in the company and its affiliates, with specific shareholdings detailed in the report [84]. - The company’s governance and compliance with the Hong Kong Stock Exchange listing rules are highlighted in the report [84]. - The board consists of seven members, including three executive directors and four non-executive directors, with a majority being independent [147]. - The company has maintained sufficient public float as per the Hong Kong Stock Exchange listing rules [140]. - The company has established a comprehensive employment management system to ensure a fair, safe, healthy, and diverse work environment [138]. - The board has taken measures to closely monitor and enhance its corporate governance practices to comply with the relevant codes [143]. Risk Management - The group has identified key risks and uncertainties that may impact its financial condition and operational performance, detailed in the risk management report [135]. - The board is responsible for maintaining effective risk management and internal control systems, with annual reviews conducted to assess their effectiveness [177]. - The internal audit department, established in 2007, evaluates the effectiveness of internal controls and risk management processes [179]. - The group aims to achieve informed decision-making based on business objectives and risk appetite [195]. - The group has established a systematic approach to identify risks and ensure compliance with relevant laws and regulations [195]. Sustainability and Social Responsibility - The company emphasizes its commitment to sustainable development and resource optimization in its operations [138]. - The company aims to enhance its environmental, social, and governance performance over time [138]. - The company has adopted whistleblowing and anti-corruption policies to promote ethical conduct within the organization [177]. - The company encourages directors to participate in professional training and seminars to enhance their knowledge and skills [171].

8 Lippo China Resources Limited 力 寶 華 潤 有 限 公 司 (於香港註冊成立之有限公司) (股份代號: 156) ２０２１ 中 期業績報告 目錄 頁次 簡明綜合損益表2 簡明綜合全面收益表3 簡明綜合財務狀況表4 簡明綜合權益變動表6 簡明綜合現金流動表7 中期財務報告書附註8 業務回顧及展望27 附加資料36 公司資料44 力寶華潤有限公司(「本公司」)之董事會欣然提呈本公司及其附屬公司(統稱「本集團)截至 2021年6月30日止六個月之未經審核簡明綜合中期財務報告書。 簡明綜合損益表 截至2021年6月30日止六個月 | --- | --- | --- | --- | |-------------------------------------------------------------------------|-------|-------------------------------------------------------|-----------------------| | | 附註 | 未經審核 \n截至以下日期止六個月 2021年 6月30日 千 ...

Lippo China Resources Limited 力 寶 華 潤 有 限 公 司 (於香港註冊成立之有限公司) (股份代號：156) ND GD GD GD GD GD GD GD CD CD 2020年報 ish as a man and as a lost as a lost of ash as a month and and 000 000 000 050 050 050 050 000 050 050 050 080 000 000 000 050 050 050 050 000 050 050 050 050 080 080 050 and and a see > 080080 on (1990) in 目錄 頁次 公司資料2 主席報告3 董事會報告5 企業管治報告 34 風險管理報告 45 環境、社會及管治報告 53 獨立核數師報告 75 綜合損益表 80 綜合全面收益表 81 綜合財務狀況表 82 綜合權益變動表 84 綜合現金流動表 86 財務報告書附註 88 主要附屬公司資料 180 主要聯營公司資料 187 主要合營企業資料 188 共同經營企業資料 189 主要物業附表 190 ...

Lippo China Resources Limited 力 寶 華 潤 有 限 公 司 (於香港註冊成立之有限公司) (股份代號:156) 業 續 中 期 報 售 目錄 頁次 簡明綜合損益表2 簡明綜合全面收益表3 簡明綜合財務狀況表4 簡明綜合權益變動表6 簡明綜合現金流動表7 中期財務報告書附註8 業務回顧及展望27 附加資料37 公司資料44 力寶華潤有限公司(「本公司」之董事會提呈本公司及其附屬公司(統稱「本集團J)截至2020年 9月30日止六個月之未經審核簡明綜合中期財務報告書。 截至2020年9月30日止六個月 簡明綜合損益表 | --- | --- | --- | --- | |---------------------------------------------------------|-------|----------------------------------------------|-------------------------| | | 附註 | 未經審核 \n截至9月30日止六個月 2020年 千港元 | 2019年 千港元 | | 收入 銷售成本 | 4 | 3 ...

Lippo China Resources Limited/ 力 寶 華 潤 有 限 公 司 (於香港註冊成立之有限公司) (股份代號：156) 2019/2020 年 報 目錄 頁次 公司資料 2 主席報告 3 董事會報告 5 企業管治報告 32 風險管理報告 43 環境、社會及管治報告 51 獨立核數師報告 77 綜合損益表 82 綜合全面收益表 83 綜合財務狀況表 84 綜合權益變動表 86 綜合現金流動表 88 財務報告書附註 90 主要附屬公司資料 184 主要聯營公司資料 191 主要合營企業資料 192 共同經營企業資料 193 主要物業附表 194 財務資料概要 196 2 力寶華潤有限公司 | 2019/2020年年報 公司資料 | --- | --- | |-----------------------------------|---------------------------| | | | | 董事會 | 秘書 | | 執行董事 | 陸苑芬女士 | | 李棕博士 （主席） | | | 李聯煒先生， BBS, JP （行政總裁） | 核數師 安永會計師事務所 | | 李小龍先生 | ...

( ( 於香港註冊成立之有限公司 股份代號: 156))中期業績報告 2019 目錄 頁次 簡明綜合損益表2 簡明綜合全面收益表3 簡明綜合財務狀況表4 簡明綜合權益變動表6 簡明綜合現金流動表7 中期財務報告書附註8 業務回顧及展望 32 附加資料 公司資料 43 50 力寶華潤有限公司（「本公司」）董事會提呈本公司及其附屬公司（統稱「本集團」）截至2019年9月30日止 六個月之未經審核簡明綜合中期財務報告書。 簡明綜合損益表 截至2019年9月30日止六個月 未經審核 截至9月30日止六個月 2019年 2018年 | --- | --- | --- | --- | |--------------------------------------------|-------|---------------------|---------------------| | | 附註 | 千港元 | 千港元 | | 收入 銷售成本 | 4 | 493,583 (143,761) | 1,270,290 (715,908) | | | | | | | 溢利總額 | | 349,822 | 554,382 | | 其 ...

8 Lippo China Resources Limited 力 寶 華 潤 有 限 公 司 (於香港註冊成立之有限公司) (股份代號：156) 2018/2019 年 報 目錄 頁次 公司資料 2 主席報告 3 董事會報告 4 企業管治報告 32 風險管理報告 43 環境、社會及管治報告 52 獨立核數師報告 77 綜合損益表 82 綜合全面收益表 83 綜合財務狀況表 84 綜合權益變動表 86 綜合現金流動表 88 財務報告書附註 90 主要附屬公司資料 191 主要聯營公司資料 199 主要合營企業資料 200 共同經營企業資料 201 主要物業附表 202 財務資料概要 204 2 力寶華潤有限公司 | 2018/2019年年報 非執行董事 陳念良先生 委員會 公司資料 董事會 執行董事 李棕博士（主席） 李聯煒先生，BBS, JP （行政總裁） 李小龍先生 獨立非執行董事 梁英傑先生 徐景輝先生 容夏谷先生 審核委員會 容夏谷先生（主席） 陳念良先生 梁英傑先生 徐景輝先生 薪酬委員會 徐景輝先生（主席） 陳念良先生 容夏谷先生 梁英傑先生 李棕博士 提名委員會 徐景輝先生（主席） 陳念良先生 ...